|
|
Hearing Disturbances as a side effect
Decreased Hearing
| Drug |
Incidence |
| Aralen |
Aricept |
| Campath |
|
| Ciprodex |
Rare |
| Clinoril |
< 1% |
| Dynacin |
Rare |
| Evoxac |
< 1% |
| Floxin |
< 1% |
| Fortovase |
< 2% |
| Invirase |
< 2% |
| Namenda |
Infrequent |
| ProSom |
Rare |
| Risperdal |
Rare |
| Topamax |
1% to 2% |
| Topamax |
1% to 2% |
| Visudyne |
1% to 10% |
Hearing Disturbances
| Drug |
Incidence |
| Amerge |
Infrequent |
| Anaprox |
< 3% |
| Avalide |
|
| Avapro |
< 1% |
| EC-Naprosyn |
< 3% |
| Floxin |
|
| Imitrex, |
Infrequent |
| Indocin |
< 1% |
| Intron A |
< 5% |
| Lupron |
|
| Naprosyn |
< 3% |
| Prevacid NapraPAC |
< 3% |
| Rebetol |
|
| Ribavirin |
|
| Roferon-A |
< 4% |
Loss of Hearing
| Drug |
Incidence |
| Abelcet |
|
| Aggrenox |
|
| Alka-Seltzer Effervescent |
|
| Altace |
< 1% |
| Ancobon |
|
| Capastat |
3% |
| Coreg |
< 0.1% |
| Demadex |
|
| Depacon |
|
| Depakene |
|
| Depakote |
|
| Desferal Vials |
|
| Dolobid |
Rare |
| Ecotrin |
|
| Fabrazyme |
|
| Floxin |
Rare |
| Fludara |
2% to 6% |
| Furosemide |
|
| Gengraf |
< 2% |
| HIVID |
< 1% |
| Imitrex |
|
| Kaopectate |
|
| Lortab |
|
| Maalox |
|
| Matulane |
|
| Miacalcin |
< 1% |
| Motrin |
< 1% |
| Neoral |
< 2% |
| Orthoclone OKT3 |
|
| PEG-Intron |
|
| Pediazole |
|
| Prevpac |
|
| Primaxin |
< 0.2% |
| Prograf |
|
| Prozac |
Rare |
| Raptiva |
|
| Retrovir |
|
| Sandimmune |
< 2% |
| Sandostatin |
< 1% |
| Tobi |
|
| Toradol |
< 1% |
| Vancocin |
< 1% |
| Vesanoid |
6% |
| Zinacef |
|
Reversible Hearing Loss
| Drug |
Incidence |
| Depacon |
Depakene |
| Depakote |
|
| E.E.S. |
Isolated reports |
| Ery-Tab |
Isolated reports |
| EryPed |
Isolated reports |
| Erythrocin |
Isolated reports |
| Erythromycin |
Isolated reports |
| PCE Dispertab |
Isolated reports |
| Pediazole |
Isolated reports |
| Romazicon |
Less than 1% |
|
This site complies with the HONcode standard for trustworthy health information: